出版國家:United Arab Emirates
出版周期:年刊
影響因子:2.821
研究領(lǐng)域:心血管藥物、心血管疾病、心血管系統(tǒng)
5年影響因子:2.889
國外數(shù)據(jù)庫收錄:IM,2.821" />
CurrentVascular Pharmacology publishesclinical and research-based reviews, original research articles, letters,debates, drug clinical trial studies and guest edited issues to update allthose concerned with the treatment of vascular disease, bridging the gapbetween clinical practice and ongoing research.
Vasculardisease is the commonest cause of death in Westernized countries and itsincidence is on the increase in developing countries. It follows thatconsiderable research is directed at establishing effective treatment for acutevascular events. Long-term treatment has also received considerable attention(e.g. for symptomatic relief). Furthermore, effective prevention, whetherprimary or secondary, is backed by the findings of several landmark trials.Vascular disease is a complex field with primary care physicians and nursepractitioners as well as several specialties involved. The latter includecardiology, vascular and cardio thoracic surgery, general medicine, radiology,clinical pharmacology and neurology (stroke units).